Proanthocyanidins prevent tau protein aggregation and disintegrate tau filaments

被引:2
|
作者
Yin, Huan-Huan [1 ]
Han, Yin -Lei [1 ]
Yan, Xiao [2 ]
Guan, Yi-Xin [1 ]
机构
[1] Zhejiang Univ, Coll Chem & Biol Engn, Hangzhou 310027, Peoples R China
[2] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany
基金
中国国家自然科学基金;
关键词
Protein; Aggregation; Disaggregation; Molecular simulation; Proanthocyanidins; Alzheimer?s disease (AD); ALZHEIMERS-DISEASE; A-BETA; MECHANISM; OLIGOMERS; INSIGHTS; MODELS;
D O I
10.1016/j.cjche.2022.09.013
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Occurrence of neurofibrillary tangles of the tau protein is a hallmark of tau-related neurodegenerative diseases, i.e. Alzheimer's disease (AD) and frontotemporal dementia. The pathological mechanism under-lying AD remains poorly understood, and effective treatments are still unavailable to mitigate the disease. Inhibiting of tau aggregation and disrupting the existing fibrils are key targets in drug discovery towards preventing or curing AD. In this study, grape seed proanthocyanidins (GSPs) was found to effectively inhi-bit the repeat domain of tau (tau-RD) aggregation and disaggregate tau-RD fibrils in a concentration -dependent manner by inhibiting b-sheet formation of tau-RD. In cells, GSPs relieved cytotoxicity induced by tau-RD aggregates. Molecular dynamics simulations indicated that strong hydrogen bonding, hydrophobic interaction and 7C -7C stacking between GSPs and tau-RD protein were major reasons why GSPs had high inhibitory activity on tau-RD fibrillogenesis. These results provide preliminary data to develop GSPs into medicines, foodstuffs or nutritional supplements for AD patients, suggesting that GSPs could be a candidate molecule in the drug design for AD therapeutics.(c) 2022 Chemical Industry and Engineering Society of China (CIESC) and Chemical Industry Press (CIP) Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 50 条
  • [11] Pathway of tau aggregation into alzheimer paired helical filaments
    Mandelkow, E.
    von Bergen, M.
    Schneider, A.
    Barghorn, S.
    Biernat, J.
    Mandelkow, E. M.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 47 - 47
  • [12] Implications of Valosin-containing Protein in Promoting Autophagy to Prevent Tau Aggregation
    Chinnathambi, Subashchandrabose
    Gorantla, Nalini Vijay
    NEUROSCIENCE, 2021, 476 : 125 - 134
  • [13] Structure of Tau filaments in Prion protein amyloidoses
    Hallinan, Grace I.
    Hoq, Md Rejaul
    Ghosh, Manali
    Vago, Frank S.
    Fernandez, Anllely
    Garringer, Holly J.
    Vidal, Ruben
    Jiang, Wen
    Ghetti, Bernardino
    ACTA NEUROPATHOLOGICA, 2021, 142 (02) : 227 - 241
  • [14] Structure of Tau filaments in Prion protein amyloidoses
    Grace I. Hallinan
    Md Rejaul Hoq
    Manali Ghosh
    Frank S. Vago
    Anllely Fernandez
    Holly J. Garringer
    Ruben Vidal
    Wen Jiang
    Bernardino Ghetti
    Acta Neuropathologica, 2021, 142 : 227 - 241
  • [15] Granular tau oligomers as intermediates of tau filaments
    Maeda, Sumihiro
    Sahara, Naruhiko
    Saito, Yuko
    Murayama, Miyuki
    Yoshiike, Yuji
    Kim, Hyonchol
    Miyasaka, Tomohiro
    Murayama, Shigeo
    Ikai, Atsushi
    Takashima, Akihiko
    BIOCHEMISTRY, 2007, 46 (12) : 3856 - 3861
  • [16] Inhibition of Tau Protein Phosphorylation and Aggregation
    Martic, Sanela
    FASEB JOURNAL, 2021, 35
  • [17] AGGREGATION OF TAU-PROTEIN BY ALUMINUM
    SCOTT, CW
    FIELES, A
    SYGOWSKI, LA
    CAPUTO, CB
    BRAIN RESEARCH, 1993, 628 (1-2) : 77 - 84
  • [18] Unraveling the mechanism of tau protein aggregation in presence of zinc ion: The earliest step of tau aggregation
    Chowdhury, S. Roy
    Lu, H. Peter
    CHEMICAL PHYSICS IMPACT, 2022, 4
  • [19] Inhibitory Effects of Isobavachalcone on Tau Protein Aggregation, Tau Phosphorylation, and Oligomeric Tau-Induced Apoptosis
    Xiao, Shifeng
    Wu, Qiuping
    Yao, Xuanbao
    Zhang, Jiahao
    Zhong, Weicong
    Zhao, Junyi
    Liu, Qiong
    Zhang, Mohan
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (01): : 123 - 132